Data from human luminal breast cancer samples showed the high vCAF and myCAF signatures were associated with radiation resistance, tumor cell heterogeneity, and cancer stemness, while iCAF signatures and CRABP5 and CD53 expression were correlated with treatment response (Nandi et al., 2022). Here, HCFC1 is linked to neoplasm.